Brief: Organon Q3 Adjusted EPS USD 1.01 Vs. IBES Estimate USD 0.94
10/11/2025 12:30
Nov 10 (Reuters) - Organon Q3 adjusted net income USD 263 million vs. IBES estimate USD 245.3 million. Q3 EPS USD 0.61 Q3 revenue USD 1,602 million vs. IBES estimate USD 1,575 million Q3 gross margin 53.5% Q3 net income USD 160 million Q3 adjusted EBITDA USD 518 million Q3 adjusted EBITDA margin 32.3% outlook FY revenue USD 6,200-6,250 million outlook FY adjusted EBITDA margin 31%
Recent news on Organon & Co.
See all newsIndia's Sun Pharma misses debt fundraise goal as investors demand higher yields, bankers say
Brief: Organon & Co Says It Does Not Expect To Record Milestone Expense In Q3 2026
India's Persistent Systems plans debut rupee debt sale to fund acquisition, bankers say
India's Sun Pharma plans $1 billion local debt sale for loan takeout, sources say
Organon & Co reports results for the quarter ended June 30 - Earnings Summary